Battle over pregnancy drug highlights risks of FDA expediting drugs to market
The years-long effort to yank the drug’s approval offers a case study of the agency’s accelerated approval program, which green-lit Makena in 2011.
Today's Liberal News
By Lauren Gardner
Battle over pregnancy drug highlights risks of FDA expediting drugs to market
The years-long effort to yank the drug’s approval offers a case study of the agency’s accelerated approval program, which green-lit Makena in 2011.
Battle over pregnancy drug highlights risks of FDA expediting drugs to market
The years-long effort to yank the drug’s approval offers a case study of the agency’s accelerated approval program, which green-lit Makena in 2011.
White House: Covid-19 boosters will become annual shot, just like the flu vaccine
The administration is making a policy change it has signaled for months.
White House: Covid-19 boosters will become annual shot, just like the flu vaccine
The administration is making a policy change it has signaled for months.
CDC recommends updated Covid-19 boosters to target Omicron strains
CDC Director Rochelle Walensky endorsed the shots
CDC recommends updated Covid-19 boosters to target Omicron strains
CDC Director Rochelle Walensky endorsed the shots
CDC recommends updated Covid-19 boosters to target Omicron strains
CDC Director Rochelle Walensky endorsed the shots
CDC recommends updated Covid-19 boosters to target Omicron strains
CDC Director Rochelle Walensky endorsed the shots
CDC recommends updated Covid-19 boosters to target Omicron strains
CDC Director Rochelle Walensky endorsed the shots
Moderna sues Pfizer and BioNTech for patent infringement on Covid vaccine technology
Moderna said it’s not seeking to have the Pfizer-BioNTech vaccine removed from the market, nor is it seeking an injunction preventing future sales.
Moderna sues Pfizer and BioNTech for patent infringement on Covid vaccine technology
Moderna said it’s not seeking to have the Pfizer-BioNTech vaccine removed from the market, nor is it seeking an injunction preventing future sales.
Moderna sues Pfizer and BioNTech for patent infringement on Covid vaccine technology
Moderna said it’s not seeking to have the Pfizer-BioNTech vaccine removed from the market, nor is it seeking an injunction preventing future sales.
Moderna sues Pfizer and BioNTech for patent infringement on Covid vaccine technology
Moderna said it’s not seeking to have the Pfizer-BioNTech vaccine removed from the market, nor is it seeking an injunction preventing future sales.
Moderna sues Pfizer and BioNTech for patent infringement on Covid vaccine technology
Moderna said it’s not seeking to have the Pfizer-BioNTech vaccine removed from the market, nor is it seeking an injunction preventing future sales.
Birth control coverage gaps scrutinized as reproductive health landscape shifts
The Biden administration is responding, working to shore up reproductive health policies it can control in the wake of the Supreme Court’s overturning of Roe v. Wade.
Birth control coverage gaps scrutinized as reproductive health landscape shifts
The Biden administration is responding, working to shore up reproductive health policies it can control in the wake of the Supreme Court’s overturning of Roe v. Wade.
Birth control coverage gaps scrutinized as reproductive health landscape shifts
The Biden administration is responding, working to shore up reproductive health policies it can control in the wake of the Supreme Court’s overturning of Roe v. Wade.
Birth control coverage gaps scrutinized as reproductive health landscape shifts
The Biden administration is responding, working to shore up reproductive health policies it can control in the wake of the Supreme Court’s overturning of Roe v. Wade.
Birth control coverage gaps scrutinized as reproductive health landscape shifts
The Biden administration is responding, working to shore up reproductive health policies it can control in the wake of the Supreme Court’s overturning of Roe v. Wade.
Abortion pill maker plans multistate legal action to preserve drug access
The company is currently challenging a Mississippi law that effectively banned telehealth abortions by making patients see doctors in person.
Abortion pill maker plans multistate legal action to preserve drug access
The company is currently challenging a Mississippi law that effectively banned telehealth abortions by making patients see doctors in person.
Abortion pill maker plans multistate legal action to preserve drug access
The company is currently challenging a Mississippi law that effectively banned telehealth abortions by making patients see doctors in person.
FDA advisers recommend strain update to Covid-19 boosters ahead of expected fall surge
The advisory committee signaled a preference for the strain composition to target the BA.4 and BA.5 subvariants.
Abortion pill maker plans multistate legal action to preserve drug access
The company is currently challenging a Mississippi law that effectively banned telehealth abortions by making patients see doctors in person.
FDA advisers recommend strain update to Covid-19 boosters ahead of expected fall surge
The advisory committee signaled a preference for the strain composition to target the BA.4 and BA.5 subvariants.
FDA advisers recommend strain update to Covid-19 boosters ahead of expected fall surge
The advisory committee signaled a preference for the strain composition to target the BA.4 and BA.5 subvariants.
Abortion pill maker plans multistate legal action to preserve drug access
The company is currently challenging a Mississippi law that effectively banned telehealth abortions by making patients see doctors in person.
FDA advisers recommend strain update to Covid-19 boosters ahead of expected fall surge
The advisory committee signaled a preference for the strain composition to target the BA.4 and BA.5 subvariants.
FDA advisers endorse administration of Moderna, Pfizer Covid-19 vaccines in babies, toddlers
The FDA is expected to quickly authorize the vaccines for emergency use.